O2 extraction maintains O2 uptake during submaximal exercise with beta-adrenergic blockade at 4,300 m. 1998

E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
Cardiovascular Pulmonary Research Laboratory, Division of Cardiology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.

Whole body O2 uptake (VO2) during maximal and submaximal exercise has been shown to be preserved in the setting of beta-adrenergic blockade at high altitude, despite marked reductions in heart rate during exercise. An increase in stroke volume at high altitude has been suggested as the mechanism that preserves systemic O2 delivery (blood flow x arterial O2 content) and thereby maintains VO2 at sea-level values. To test this hypothesis, we studied the effects of nonselective beta-adrenergic blockade on submaximal exercise performance in 11 normal men (26 +/- 1 yr) at sea level and on arrival and after 21 days at 4,300 m. Six subjects received propranolol (240 mg/day), and five subjects received placebo. At sea level, during submaximal exercise, cardiac output and O2 delivery were significantly lower in propranolol- than in placebo-treated subjects. Increases in stroke volume and O2 extraction were responsible for the maintenance of VO2. At 4,300 m, beta-adrenergic blockade had no significant effect on VO2, ventilation, alveolar PO2, and arterial blood gases during submaximal exercise. Despite increases in stroke volume, cardiac output and thereby O2 delivery were still reduced in propranolol-treated subjects compared with subjects treated with placebo. Further reductions in already low levels of mixed venous O2 saturation were responsible for the maintenance of VO2 on arrival and after 21 days at 4,300 m in propranolol-treated subjects. Despite similar workloads and VO2, propranolol-treated subjects exercised at greater perceived intensity than subjects given placebo at 4,300 m. The values for mixed venous O2 saturation during submaximal exercise in propranolol-treated subjects at 4,300 m approached those reported at simulated altitudes >8,000 m. Thus beta-adrenergic blockade at 4,300 m results in significant reduction in O2 delivery during submaximal exercise due to incomplete compensation by stroke volume for the reduction in exercise heart rate. Total body VO2 is maintained at a constant level by an interaction between mixed venous O2 saturation, the arterial O2-carrying capacity, and hemodynamics during exercise with acute and chronic hypoxia.

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008297 Male Males
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D001784 Blood Gas Analysis Measurement of oxygen and carbon dioxide in the blood. Analysis, Blood Gas,Analyses, Blood Gas,Blood Gas Analyses,Gas Analyses, Blood,Gas Analysis, Blood
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic

Related Publications

E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
April 1983, Journal of applied physiology: respiratory, environmental and exercise physiology,
E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
December 2001, American journal of physiology. Heart and circulatory physiology,
E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
January 2000, Journal of applied physiology (Bethesda, Md. : 1985),
E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
March 1985, Acta physiologica Scandinavica,
E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
November 2003, Journal of applied physiology (Bethesda, Md. : 1985),
E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
May 2001, American journal of physiology. Endocrinology and metabolism,
E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
November 2003, Metabolism: clinical and experimental,
E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
November 1983, International journal of sports medicine,
E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
April 1985, The American journal of cardiology,
E E Wolfel, and M A Selland, and A Cymerman, and G A Brooks, and G E Butterfield, and R S Mazzeo, and R F Grover, and J T Reeves
February 1996, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!